Jinju Biomedicine Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 2

Jinju Biomedicine General Information

Description

Manufacturer of a cell-therapy biopharmaceutical products company intended to develop stem-cell spheroid therapies. The company offers a stem cell sphere treatment, injectable stem-cell products, and multiple therapeutic-area coverage (joints, heart, anti-aging, etc.), enabling clinical and medical-cosmetic developers to access advanced regenerative therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 699-18 Xuanwu Avenue
  • Xuanwu District
  • Nanjing, 210000
  • China
+86 158
Primary Industry
Biotechnology
Corporate Office
  • Number 699-18 Xuanwu Avenue
  • Xuanwu District
  • Nanjing, 210000
  • China
+86 158

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jinju Biomedicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 19-Nov-2025 Completed Generating Revenue
To view Jinju Biomedicine’s complete valuation and funding history, request access »

Jinju Biomedicine Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sinopharm Group Corporation Minority
Tenyall Investment Venture Capital Minority
To view Jinju Biomedicine’s complete investors history, request access »

Jinju Biomedicine FAQs

  • When was Jinju Biomedicine founded?

    Jinju Biomedicine was founded in 2024.

  • Where is Jinju Biomedicine headquartered?

    Jinju Biomedicine is headquartered in Nanjing, China.

  • What industry is Jinju Biomedicine in?

    Jinju Biomedicine’s primary industry is Biotechnology.

  • Is Jinju Biomedicine a private or public company?

    Jinju Biomedicine is a Private company.

  • What is Jinju Biomedicine’s current revenue?

    The current revenue for Jinju Biomedicine is .

  • Who are Jinju Biomedicine’s investors?

    Sinopharm Group and Tenyall Investment have invested in Jinju Biomedicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process